A2DMQY Cronos Group Inc

Cronos Group Inc. to Report 2019 Fourth Quarter and Full-Year Financial Results on March 30, 2020

Cronos Group Inc. to Report 2019 Fourth Quarter and Full-Year Financial Results on March 30, 2020

TORONTO, March 30, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will report its 2019 Fourth Quarter and Full-Year Financial Results on Monday, March 30, 2020 after the close of trading on NASDAQ.

The Company will host a conference call to discuss these results, its outlook and other matters on Monday, March 30, 2020 at 5:30 p.m. EDT. Cronos Group’s senior management team will discuss its financial results and will be available for questions from the investment community after prepared remarks.

A live audio webcast of the earnings call will be available on the Company’s website at . Participants may also listen via telephone by dialing (866) 795-2258 toll-free from the U.S. and Canada, or (409) 937-8902 if dialing from outside the U.S. and Canada, with passcode: 6999389. The webcast of the call will be archived on the Company’s website.

About Cronos Group Inc.

Cronos Group is an innovative global cannabinoid company with international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos Group is building an iconic brand portfolio. Cronos Group’s portfolio includes ™, a global wellness platform, two adult-use brands, ™ and ™, and two hemp-derived CBD brands, ™ and ™. For more information about Cronos Group and its brands, please visit: 

Cronos Group Contact

Anna Shlimak

Tel: (416) 504-0004

EN
30/03/2020

Underlying

A2DMQYCronos Group Inc

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cronos Group Inc

 PRESS RELEASE
Free
A2DMQY Cronos Group In...

Cronos Group Inc. to Hold 2025 First Quarter Earnings Conference Call ...

Cronos Group Inc. to Hold 2025 First Quarter Earnings Conference Call on May 8, 2025 TORONTO, April 24, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 first quarter earnings conference call on Thursday, May 8, 2025 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at . To avoid delays, we encourage participants ...

April 24, 2025 1 EN
 PRESS RELEASE
Free
A2DMQY Cronos Group In...

Cronos Unveils New Spinach® 1.2g Vapes and SOURZ by Spinach® Gummies E...

Cronos Unveils New Spinach® 1.2g Vapes and SOURZ by Spinach® Gummies Enhanced with Rare Cannabinoids TORONTO, April 22, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc.’s (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) best-selling cannabis brand, Spinach®, is thrilled to introduce three all-new 1.2g vape products, each expertly crafted with premium THC and enhanced with rare cannabinoids for a uniquely elevated experience. Along with these innovative vape offerings, Cronos is also unveiling new SOURZ by Spinach® Fully Blasted flavors, infused with rare cannabinoids. The new lineup incl...

April 22, 2025 1 EN
 PRESS RELEASE
Free
A2DMQY Cronos Group In...

Cronos Appoints Anna Shlimak as Chief Financial Officer

Cronos Appoints Anna Shlimak as Chief Financial Officer TORONTO, March 19, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced the appointment of Anna Shlimak as Chief Financial Officer, effective today. Ms. Shlimak, who previously served as Cronos’ Chief Strategy Officer, will succeed James Holm who is stepping down to pursue other opportunities and will remain with the Company through April 18, 2025 to ensure a seamless transition. Ms. Shlimak has been an integral part of Cronos...

March 19, 2025 1 EN
 PRESS RELEASE
Free
A2DMQY Cronos Group In...

Cronos Group Inc. to Speak at the 37th Annual Roth Conference

Cronos Group Inc. to Speak at the 37th Annual Roth Conference TORONTO, March 10, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at the 37th Annual Roth Conference on Monday, March 17, 2025, at 1:00 PM PT. A live webcast will be available on the Investors section of the Company’s website at . About Cronos Group Inc.Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property...

March 10, 2025 1 EN
 PRESS RELEASE
Free
A2DMQY Cronos Group In...

Cronos Group Reports 2024 Fourth Quarter and Full-Year Results

Cronos Group Reports 2024 Fourth Quarter and Full-Year Results Net revenue in Q4 2024 increased by 27% year-over-year to $30.3 million; Net revenue in FY 2024 increased by 35% year-over-year to $117.6 million Spinach® Ends 2024 as the Number One Cannabis Brand in Canada1 PEACE NATURALS® Ends 2024 as the Number One Cannabis Brand in Israel 2 Industry leading balance sheet with $859 million in cash and cash equivalents TORONTO, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), today announced its 2024 fourth quarter and ...

February 27, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch